Charlotte Hubbard

Charlotte Hubbard is an advisor at Ozette Technologies and a board member at Lodo Therapeutics. Charlotte has also served on the boards of NanoString Technologies, Inc., Galileo Biosystems, Entrinsic Health Solutions, and Vedanta Biosciences, Inc.

Charlotte has a background in investments and development in biotechnology companies. Charlotte has been involved with companies working on cutting-edge innovations in the fields of infectious diseases, immune programming, and pathogen-host interactions.

Charlotte is a member of the board of directors at Accelerator, a privately-held biotechnology investment and development company. Charlotte is also a member of the board of directors at Vir Biotechnology, Inc., a company that is focused on developing solutions for infectious diseases.

Charlotte Hubbard has a PhD in Molecular Cancer Biology from Duke University and a B.S. in Microbiology from the University of Washington.